| |
| |
|
| Insider
Information: |
Ertel Steven D |
| Relationship: |
EVP & Chief Operating ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
136,977 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,484,639 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
136,977 |
|
|
| Total
Value |
$24,484,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
EVP & Chief Operating ... |
2017-03-02 |
136,977 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business OfficerOf |
• – – |
2013-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,656 |
|
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-04-22 |
4 |
OE |
$0.40 |
$1,000 |
D/D |
2,500 |
30,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-04-22 |
4 |
AS |
$35.75 |
$89,669 |
D/D |
(2,500) |
27,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-05-19 |
4 |
OE |
$0.40 |
$39,100 |
D/D |
10,000 |
35,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-05-19 |
4 |
AS |
$31.48 |
$315,189 |
D/D |
(10,000) |
27,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-06-02 |
4 |
S |
$29.73 |
$74,325 |
D/D |
(2,500) |
27,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-06-02 |
4 |
OE |
$0.40 |
$39,100 |
D/D |
10,000 |
30,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-06-02 |
4 |
AS |
$29.71 |
$222,891 |
D/D |
(7,500) |
27,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-06-17 |
4 |
OE |
$3.88 |
$31,040 |
D/D |
8,000 |
35,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-07-01 |
4 |
OE |
$0.40 |
$39,100 |
D/D |
10,000 |
38,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-07-01 |
4 |
AS |
$34.09 |
$340,925 |
D/D |
(10,000) |
35,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-07-30 |
4 |
OE |
$3.88 |
$31,040 |
D/D |
8,000 |
43,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-08-14 |
4 |
OE |
$0.40 |
$39,100 |
D/D |
10,000 |
51,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-08-14 |
4 |
AS |
$29.77 |
$297,785 |
D/D |
(10,000) |
43,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-08-25 |
4 |
OE |
$3.88 |
$34,920 |
D/D |
9,000 |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-09-02 |
4 |
OE |
$0.40 |
$39,100 |
D/D |
10,000 |
55,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-09-02 |
4 |
AS |
$26.43 |
$264,375 |
D/D |
(10,000) |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-10-01 |
4 |
OE |
$0.40 |
$29,025 |
D/D |
10,000 |
57,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-10-01 |
4 |
AS |
$29.53 |
$296,567 |
D/D |
(10,000) |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-11-12 |
4 |
OE |
$0.92 |
$30,000 |
D/D |
10,000 |
57,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-11-12 |
4 |
AS |
$32.45 |
$331,405 |
D/D |
(10,000) |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-12-01 |
4 |
AS |
$34.89 |
$268,988 |
D/D |
(7,500) |
52,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2014-12-01 |
4 |
OE |
$0.92 |
$19,913 |
D/D |
7,500 |
55,156 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2015-01-02 |
4 |
OE |
$1.80 |
$9,000 |
D/D |
5,000 |
57,656 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP & Chief Business Officer |
• – – |
2015-01-02 |
4 |
AS |
$38.32 |
$192,328 |
D/D |
(5,000) |
52,656 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
